| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5637320 | TWI PHARMS | Controlled absorption naproxen formulation for once-daily administration |
Jun, 2014
(9 years ago) | |
Naprelan is owned by Twi Pharms.
Naprelan contains Naproxen Sodium.
Naprelan has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Naprelan are:
- US5637320
Naprelan was authorised for market use on 05 January, 1996.
Naprelan is available in tablet, extended release;oral dosage forms.
The generics of Naprelan are possible to be released after 10 June, 2014.
Drugs and Companies using NAPROXEN SODIUM ingredient
Market Authorisation Date: 05 January, 1996
Treatment: NA
Dosage: TABLET, EXTENDED RELEASE;ORAL
How can I launch a generic of NAPRELAN before it's drug patent expiration?
More Information on Dosage
NAPRELAN family patents
